Methods |
Type of study: RCT Method of treatment allocation: method of randomisation not stated. Stratification: none stated Placebo: no Sample size calculation: no Intention‐to‐treat analyses: no Losses to follow‐up: yes, number of post‐randomisation exclusions not stated Funding: not stated |
Participants |
Location: CHU Farhat Hached, Sousse, Tunisia Timeframe: January 1998‐June 1999 Eligibility criteria: women in preterm labour Gestational age range: 26‐34 weeks Exclusion criteria: gestational diabetes, > 4 cm cervical dilatation, fetal abnormalities, contraindication to corticosteroids, delivery elsewhere or after 34 weeks (post‐randomisation exclusions) Total recruited: 118 women and 131 infants; 59 women and 63 infants in the treatment arm and 59 women and 68 infants in the control arm |
Interventions |
Abstract and full report state slightly different protocols for the intervention arm. The abstract stated that 24 mg betamethasone was given as two 12 mg IM doses at 24 h apart. The full text states that this regimen was repeated weekly. Women had two doses of 12 mg given 24 h apart, and this regimen was repeated weekly. Control group received expectant management |
Outcomes |
Maternal outcomes (chorioamnionitis, postnatal fever) and fetal/neonatal outcomes reported (neonatal death, RDS, IVH) |
Notes |
Article in French, abstract in English. Article translated by review authors (La Tunisie Medicale, 2002, Vol 80; No. 5: 260‐265). Further information was requested from the study authors but there was no reply |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Method of randomisation not stated |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment was not stated |
Blinding of participants and personnel (performance bias) All outcomes |
High risk |
Blinding is unlikely as placebo was not used |
Blinding of outcome assessment (detection bias) All outcomes |
Unclear risk |
Blinding of outcome assessors was not described |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
Number of post‐randomisation exclusions not stated |
Selective reporting (reporting bias) |
Low risk |
Study protocol not available, but appears to report on all pre‐specified outcomes |
Other bias |
Unclear risk |
Insufficient information to asses if other sources of bias exist |